ASLN logo

ASLN EBITDA

Annual EBITDA

-$39.41 M
+$7.87 M+16.65%

December 31, 2023

Summary

Performance

1-Year Change

+16.65%

3-Year Change

-155.49%

5-Year Change

+4.89%

15-Year Change

-0.37%

ASLN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.04 M

3-Year Low

-$47.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ASLN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ASLN next annual earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

Annual Revenue

$12.00 M
ASLN annual revenue is $12.00 million

Annual Net Income

-$44.22 M
ASLN annual net profit is -$44.22 million

Annual EBIT

-$39.76 M
ASLN annual earnings before interest & taxes is -$39.76 million

Annual EPS

-$22.00
ASLN annual earnings per share is -$22.00

Quarterly EBITDA

-$9.25 M
+$3.23 M+25.85%

March 31, 2024

Summary

Performance

3-Month Change

+25.85%

1-Year Change

+48.68%

3-Year Change

-76.43%

5-Year Change

-76.43%

ASLN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.39 M
ASLN quarterly EBITDA is currently -271.64% below its historical high of $5.39 million

3-Year Low

-$18.03 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

Quarterly Revenue

-
ASLN quarterly revenue value is unknown

Quarterly Net Income

-$9.92 M
ASLN quarterly net profit is -$9.92 million

Quarterly EBIT

-$9.25 M
ASLN quarterly earnings before interest & taxes is -$9.25 million

Quarterly EPS

-$4.00
ASLN quarterly earnings per share is -$4.00

TTM EBITDA

-$30.98 M
+$8.78 M+22.08%

March 31, 2024

Summary

Performance

3-Month Change

+22.08%

1-Year Change

+42.4%

3-Year Change

-49.41%

5-Year Change

-49.41%

ASLN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.58 M

3-Year Low

-$53.79 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

TTM Revenue

-
ASLN TTM revenue value is unknown

TTM Net Income

-$35.03 M
ASLN TTM net profit is -$35.03 million

TTM EBIT

-$30.98 M
ASLN TTM earnings before interest & taxes is -$30.98 million

TTM EPS

-$14.92
ASLN TTM earnings per share is -$14.92

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$39.41 M
ASLN annual EBITDA is -$39.41 million

Annual Net Income

-$44.22 M
ASLN annual net profit is -$44.22 million

Annual Interest Expense

$4.33 M
ASLN annual interest expense is $4.33 million

Annual Income Tax

$132.70 K
ASLN annual income tax is $132.70 thousand

Annual D&A

$348.50 K
ASLN annual depreciation & amortization is $348.50 thousand

ASLN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.6%+48.7%+42.4%
3 y3 years-155.5%-76.4%-49.4%
5 y5 years+4.9%-76.4%-49.4%

ASLN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+33.8%+20.0%+1222.1%+94.9%+9.7%+73.6%
5 y5-year+155.5%+20.0%+1222.1%+215.7%+98.9%+73.6%
alltimeall time+459.5%+20.0%-271.6%+215.7%+1858.6%+73.6%

ASLAN Pharmaceuticals Limited EBITDA History

DateAnnualQuarterlyTTM
Mar 2024
-
-$9.25 M(-25.9%)
-$30.98 M(-22.1%)
Dec 2023
-$39.41 M(-16.6%)
-$12.48 M(+46.0%)
-$39.76 M(-2.8%)
Sep 2023
-
-$8.55 M(+1121.6%)
-$40.91 M(-3.4%)
Jun 2023
-
-$699.90 K(-96.1%)
-$42.33 M(-21.3%)
Mar 2023
-
-$18.03 M(+32.3%)
-$53.79 M(+13.0%)
Dec 2022
-$47.28 M(+60.6%)
-$13.63 M(+36.7%)
-$47.62 M(+12.4%)
Sep 2022
-
-$9.97 M(-18.0%)
-$42.37 M(+4.7%)
Jun 2022
-
-$12.16 M(+2.6%)
-$40.46 M(+20.6%)
Mar 2022
-
-$11.85 M(+41.3%)
-$33.55 M(+18.7%)
Dec 2021
-$29.45 M(+90.9%)
-
-
Dec 2021
-
-$8.39 M(+4.1%)
-$28.25 M(+12.4%)
Sep 2021
-
-$8.06 M(+53.6%)
-$25.14 M(+21.2%)
Jun 2021
-
-$5.24 M(-20.0%)
-$20.74 M(+7.8%)
Mar 2021
-
-$6.56 M(+24.3%)
-$19.24 M(+23.5%)
Dec 2020
-$15.43 M(-66.0%)
-$5.28 M(+44.2%)
-$15.58 M(-60.6%)
Sep 2020
-
-$3.66 M(-2.4%)
-$39.52 M(-3.2%)
Jun 2020
-
-$3.75 M(+29.5%)
-$40.81 M(-7.9%)
Mar 2020
-
-$2.89 M(-90.1%)
-$44.32 M(-2.7%)
Dec 2019
-$45.31 M
-
-
Dec 2019
-
-$29.21 M(+489.7%)
-$45.57 M(+66.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$4.95 M(-31.7%)
-$27.32 M(-18.2%)
Jun 2019
-
-$7.26 M(+75.2%)
-$33.41 M(-9.8%)
Mar 2019
-
-$4.14 M(-62.3%)
-$37.02 M(-10.8%)
Dec 2018
-$41.44 M(+5.5%)
-
-
Dec 2018
-
-$10.97 M(-0.6%)
-$41.50 M(-7.6%)
Sep 2018
-
-$11.04 M(+1.6%)
-$44.89 M(+7.9%)
Jun 2018
-
-$10.87 M(+26.1%)
-$41.61 M(+4.6%)
Mar 2018
-
-$8.62 M(-40.0%)
-$39.79 M(+1.2%)
Dec 2017
-$39.27 M(+359.9%)
-
-
Dec 2017
-
-$14.37 M(+85.2%)
-$39.30 M(+24.1%)
Sep 2017
-
-$7.76 M(-14.2%)
-$31.66 M(+71.0%)
Jun 2017
-
-$9.04 M(+11.2%)
-$18.52 M(+46.3%)
Mar 2017
-
-$8.13 M(+20.7%)
-$12.66 M(+52.1%)
Dec 2016
-$8.54 M(-30.5%)
-
-
Dec 2016
-
-$6.74 M(-225.0%)
-$8.32 M(+425.9%)
Sep 2016
-
$5.39 M(-269.4%)
-$1.58 M(-77.3%)
Jun 2016
-
-$3.18 M(-16.1%)
-$6.97 M(+83.9%)
Mar 2016
-
-$3.79 M
-$3.79 M
Dec 2015
-$12.29 M(+74.5%)
-
-
Dec 2014
-$7.04 M
-
-

FAQ

  • What is ASLAN Pharmaceuticals Limited annual EBITDA?
  • What is the all time high annual EBITDA for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited annual EBITDA year-on-year change?
  • What is ASLAN Pharmaceuticals Limited quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited quarterly EBITDA year-on-year change?
  • What is ASLAN Pharmaceuticals Limited TTM EBITDA?
  • What is the all time high TTM EBITDA for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited TTM EBITDA year-on-year change?

What is ASLAN Pharmaceuticals Limited annual EBITDA?

The current annual EBITDA of ASLN is -$39.41 M

What is the all time high annual EBITDA for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high annual EBITDA is -$7.04 M

What is ASLAN Pharmaceuticals Limited annual EBITDA year-on-year change?

Over the past year, ASLN annual EBITDA has changed by +$7.87 M (+16.65%)

What is ASLAN Pharmaceuticals Limited quarterly EBITDA?

The current quarterly EBITDA of ASLN is -$9.25 M

What is the all time high quarterly EBITDA for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high quarterly EBITDA is $5.39 M

What is ASLAN Pharmaceuticals Limited quarterly EBITDA year-on-year change?

Over the past year, ASLN quarterly EBITDA has changed by +$8.78 M (+48.68%)

What is ASLAN Pharmaceuticals Limited TTM EBITDA?

The current TTM EBITDA of ASLN is -$30.98 M

What is the all time high TTM EBITDA for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high TTM EBITDA is -$1.58 M

What is ASLAN Pharmaceuticals Limited TTM EBITDA year-on-year change?

Over the past year, ASLN TTM EBITDA has changed by +$22.81 M (+42.40%)